Key result
Progression to severe AS linked to ~13-point lower mortality vs stable moderate AS.
Why the study?
Moderate aortic stenosis in elderly patients is heterogeneous with survival often influenced by non-cardiovascular comorbidities, and the prognostic significance of haemodynamic progression in this population remains unclear.
Does haemodynamic progression to severe aortic stenosis predict all-cause and cardiovascular mortality in elderly patients with moderate aortic stenosis?
Cohort (n=329)
Does haemodynamic progression to severe aortic stenosis predict all-cause and cardiovascular mortality in elderly patients with moderate aortic stenosis?
Answers are grounded in this paper and cite their sources.
In elderly patients with moderate aortic stenosis, haemodynamic progression to severe AS is dissociated from overall survival due to high competing non-cardiovascular mortality, highlighting the need for holistic patient assessment rather than relying on haemodynamic trajectory alone.
Background Moderate aortic stenosis (AS) in elderly patients is heterogeneous, and survival is often influenced by non-cardiovascular comorbidities. The prognostic significance of haemodynamic progression in this population remains unclear. Methods We retrospectively analysed 329 patients with newly diagnosed moderate AS (2015–2016), excluding mild AS, bicuspid valves, and significant concomitant valvular disease. A subgroup of 186 patients with long-term follow-up was stratified by progression to severe AS: rapid (≤3 years), intermediate (4–9 years), or non-progressors (≥10 years). Associations between baseline characteristics, progression, and mortality were assessed over a median follow-up of 59 months (IQR 19–105). Results Mean age was 78±10 years and 53% (174/329) were male. Overall, 30% (99/329) of patients progressed to severe AS; older age and higher baseline mean gradient independently predicted progression (p<0.05). Rapid progressors had higher baseline Vmax and mean gradients despite similar aortic valve area. Overall mortality was high (79.6%) and predominantly non-cardiovascular. Patients with stable moderate AS exhibited a higher all-cause mortality rate than those who progressed to severe AS (83.5% vs. 70.7%, p = .008). (Figure 1) Similarly, a higher incidence of cardiovascular death was observed in the stable moderate group (16.5% vs. 15.2%, p = .030). In our subgroup analysis, non-progressors had the highest mortality (89.8%) compared with rapid (72.5%) and intermediate (68.9%) progressors (p=0.007). Cardiovascular mortality was low overall (8–16%).(Figure 2) Conclusion In elderly moderate AS, haemodynamic progression is common but does not predict overall mortality, which is largely driven by non-cardiovascular comorbidity. The shorter survival among non-progressors reflects competing-risk effects, demonstrating a dissociation between disease progression and survival. These findings question the prognostic value of haemodynamic trajectory alone and emphasize the need for holistic patient assessment when guiding management strategies.
No takes yet. Share an insight, caveat, or question.
Oo et al. (2026) conducted a cohort in Moderate aortic stenosis (n=329). Progression to severe aortic stenosis vs. Stable moderate aortic stenosis was evaluated on All-cause mortality (p=0.008). Haemodynamic progression to severe AS was associated with lower all-cause mortality than stable moderate AS (70.7% vs 83.5%, p=0.008), reflecting competing non-cardiovascular mortality.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: